期刊文献+

PKC-α反义核酸对宫颈癌HeLa细胞增殖及细胞周期的影响 被引量:1

Effect of PKC-α asODN on proliferation and cell cycle in HeLa cells of cervical carcinoma/
下载PDF
导出
摘要 目的 :探讨 PKC-α反义核酸对 He L a细胞增殖及细胞周期的影响。方法 :采用脂质体 (L P)介导法 ,用 0 .0 1~1.0 0μmol/L各浓度 PKC-α反义核酸 (as ODN)转染 He L a细胞 ;MTT法及软琼脂克隆形成法分别检测 He L a细胞生长指数 (growth index,GI)及其体外增殖能力 ;流式细胞术分析细胞周期。结果 :PKC- α as ODN0 .0 5~ 1.0 0 μmol/L 各浓度组 He L a细胞 GI显著降低 (P<0 .0 5 ) ,且呈量效依赖关系 ;其中 1.0 0μmol/L和 0 .5 0μm ol/L PKC-α as ODN对He L a细胞生长有非常显著抑制作用 (P<0 .0 1) ;0 .5 0 μmol/L PKC- α as ODN组 He L a细胞软琼脂克隆形成率均低于对照组 (P<0 .0 5 ) ;反义 PKC- α使细胞 G2 期百分比增高 (P<0 .0 1)。结论 :反义 PKC- α可通过阻滞细胞于 G2 期从而抑制 He L a细胞的生长。 Objective: To investigate the effect of antisense oligonucleotides of PKC-αon proliferation and cell cycle in HeLa cells of cervical carcinoma.Methods: PKC-α antisense oligonucleotides(asODN) and a random sequence as a control were transfected into HeLa cells by lipofectin(LP). The cell growth index (GI) and the clone formation rate of HeLa were detected by MTT and soft agar assay, respectively. Cell cycle was analyze by flow cytometry. Results: The GI of HeLa cells transfected by PKC-α asODN with concentration ranging from 0.05μm to 1.00μm was lower significantly than that of control groups(P<0.05), and there was a dose-dependent relationship among them. The inhibitive effects of 0.50μm and 1.00μm PKC-α asODN on the cell proliferation were strongest(P<0.01),and there was no significant difference between the two concentrations. After treated with antisense PKC-α, the percentage of cells in G 2 phase enhanced (P<0.01). Conclusion:Antisense PKC-αmay can inhibit cell growth in HeLa via hindering cell process in G 2 phase.
出处 《华夏医学》 2004年第6期871-873,共3页 Acta Medicinae Sinica
关键词 蛋白激酶C 反义寡核苷酸 HELA细胞 细胞周期 PKC-α asODN HeLa cell cycle
  • 相关文献

参考文献10

  • 1石法武,任洪波,张兆山,王会信,周廷冲.蛋白激酶C抑制剂staurosporine对HeLa细胞周期的影响[J].中国生物化学与分子生物学报,1998,14(1):113-11. 被引量:4
  • 2胡江,柳惠图.PKC对HeLa细胞G_1/S期进程调控及其机理的研究[J].科学通报,1999,44(19):2080-2084. 被引量:2
  • 3郝智慧,柳惠图,王端顺.PKA和PKC对HeLa细胞G_2/M/G_1进程的影响[J].北京师范大学学报(自然科学版),2000,36(2):264-267. 被引量:2
  • 4[4]Dean N,Mckay R,Miraglia L,et al.Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression[J].Cancer Res,1996,56(10):3499-3507.
  • 5[5]Felgner PL,Gadek TR,Holm M,et al.Lipofection:a highlyefficient lipidemediated DNA-transfection procedure[J].Proc Natl Acad Sci USA,1987,88:7413-7417.
  • 6袁仕善,周智广.阳离子脂质体与基因转移[J].生理科学进展,1997,28(2):163-165. 被引量:12
  • 7[7]Frey MR,Clark JA,Leontieva O,et al.Protein kinase C signaling mediates a program of cell cycle withdrawl in the intestinal epithelium[J].J-Cell-Biol,2000,151(4):763-778.
  • 8[8]Black JD.Protein kinase C-mediated regulation of the cell cycle[J].Front-Biosci,2000,5:406-423.
  • 9[9]Graham MA,Rawe I,Dartt DA,et al.Protein kinase C regulation of corneal endothelial cell proliferation and cell cycle[J].Invest-Ophthamol-Vis-Sci,2000,41(13):4124-4132.
  • 10[10]Besson A,Yong VW.Involvement of p21(Waf1/cip1) in protein kinase C alpha medual cell cycle[J].Progression Mol-Cell-Biol,2000,20(13):4580-4590.

二级参考文献9

  • 1Gao X,Biochemistry,1995年,35卷,1027页
  • 2Xiao H Z,BBA,1994年,1189卷,195页
  • 3杨静平,生物化学与生物物理学报,1994年,26卷,123页
  • 4Zhu N,Science,1993年,261卷,209页
  • 5James B M,J Cell Biol,1996年,102卷,1430页
  • 6章静波,细胞生物学实用方法与技术,1995年,35页
  • 7Galaktinov K,Nature,1996年,382卷,511页
  • 8Takuwa N,Biochem Biolphys Res Commun,1992年,188卷,3期,1084页
  • 9刘毅,艾兆伟,陈惠黎.视黄酸对人肝癌细胞蛋白激酶的影响[J].生物化学杂志,1990,6(6):553-557. 被引量:8

共引文献15

同被引文献12

  • 1蔡良真.木犀草素对人白血病HL-60细胞内蛋白激酶C的抑制作用[J].右江医学,2005,33(2):106-108. 被引量:11
  • 2张芳芳,沈汉明,朱心强.木犀草素抗肿瘤作用的研究进展[J].浙江大学学报(医学版),2006,35(5):573-578. 被引量:55
  • 3李星霞,郭澄.木犀草素的药理活性研究[J].中国药房,2007,18(18):1421-1424. 被引量:52
  • 4Sasaki N, Toda T, Kaneko T, et al. Protective effects of flavonoids on the cytotoxicity of linoleic acid hydroperoxide toward rat pheo- chromoeytoma PC12 cells [ J]. Chem Biol Interact,2003,145 ( 1 ) : 101 -116.
  • 5Horv6thov0 K, Chalupa I, Sebov6 L, et al. Protective effect of quercetin and luteolin in human melanoma HMB - 2 cells [ Jl. Murat Res,2005,565(2) :105 -112.
  • 6Mackay HJ,Twelves CJ. Protein kinase C:a target for anticancer drugs? [ J ]. Endocr Relat Cancer,2003,10 (3) :389 - 396.
  • 7Mellor H, Parker PJ . The extended protein kinase C supeffamily [J]. BiochemJ, 1998,332 (Pt2):281-292.
  • 8Tsai JH, Hsieh YS, Kuo SJ, et al. Alteration in the expression of protein kinase C isofo~ns in human hepatocellular carcinoma [ J ]. Cancer Lett,2000,161 (2) : 171 - 175.
  • 9Jarvis WD, Grant S. Protein kinase C targeting in antineoplastic treatment strategies [ J ]. Invest New Drugs, 1999,17 ( 3 ) : 227 - 240.
  • 10Horinaka M, Yoshida T, Shiraishi T, et al. The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells [J]. Biochem Biophys Res Commun, 2005,333 (3) : 833 - 838.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部